| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |